Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pharmacovigilance Market to grow at 10% CAGR from 2017 to 2024

Similar presentations


Presentation on theme: "Pharmacovigilance Market to grow at 10% CAGR from 2017 to 2024"— Presentation transcript:

1 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024 Pharmacovigilance Market Analysis, Industry Trends, Research Report 2024: Global Market Insights Inc.

2 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Increasing adverse drug reactions across the globe will fuel need for pharmacovigilance services escalating pharmacovigilance market growth over forecast timeframe.  Adverse drug reactions are among the common causes of death and morbidity within hospital settings.  Pharmacovigilance Market size is set to exceed USD 8 billion by 2024; according to a new research report by Global Market Insights.  Personalized medicine industry has witnessed rapid growth due to increased usage and acceptance in the field of cancer therapeutics.  Regulatory authorities relentless efforts to bring harmonization in pharmacovigilance practices will impact the industry growth.  Phase III trial is estimated to grow at highest CAGR from 2017 to 2024 as compared to other clinical trial segments. Key Insights from Pharmacovigilance Market:

3 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Phase IV trial segment dominated pharmacovigilance market and trend is likely to continue in forthcoming years due to rising awareness and favorable regulations pertaining to post marketing surveillance.  However, state of art infrastructure and skilled staff required for in house pharmacovigilance is difficult to maintain and comes with the additional operational cost.  Japan dominated Asia Pacific pharmacovigilance market due to robust adverse drug reaction reporting system and healthcare infrastructure.  India has well established presence of many industry players including TCS, Cognizant and more.  Some of the key industry players operating in global Pharmacovigilance market are Accenture, Boehringer Ingelheim, Bristol-Myers Squibb, Cognizant Technology Solutions Corporation, F. Hoffmann-La Roche, GlaxoSmithKline, IQVIA (QuintilesIMS), IBM Corporation, Infosys, Janssen Research & Development, Ipca Laboratories, ITclinical, Laboratory Corporation of America Holdings, Novartis AG, Pfizer, Sanofi Aventis, TCS, and Wipro. Continued...

4 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com India Pharmacovigilance Market, By Clinical Trial Phase, 2012 - 2024

5 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On Pharmacovigilance Market @ https://bit.ly/2i8RiRE https://bit.ly/2i8RiRE Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/853 https://www.gminsights.com/request-sample/detail/853 https://www.gminsights.com/request-sample/detail/49

6 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media:


Download ppt "Pharmacovigilance Market to grow at 10% CAGR from 2017 to 2024"

Similar presentations


Ads by Google